Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostate-specific transcript 1 (PCGEM1)
- Target
- PCGEM1
- Molecular classification
- Other (Long non-coding RNA; not a protein-coding gene)
01
Overview
PCGEM1 (Prostate-specific transcript 1) is a long non-coding RNA expressed predominantly in prostate tissue. It has been implicated in prostate cancer biology, with increased expression noted in cancerous prostate cells. PCGEM1 is not a classical therapeutic target (such as a receptor, enzyme, or transporter), but its role in cancer has made it the subject of research as a potential biomarker for diagnosis or prognosis. No evidence was found that ENSG00000278406 (PCGEM1) represents a currently recognized drug target or receptor. It should be classified as a long non-coding RNA associated with prostate cancer, primarily relevant as a biomarker rather than as a molecule for direct pharmacological intervention.
- Other names
- PCGEM1Prostate-specific transcript 1
02
Biological functions
lncRNA implicated in prostate cancer; likely involved in regulation of gene expression and cellular proliferation specific to prostate tissue
03
Disease associations
Cancer (specifically, prostate cancer; PCGEM1 has been studied in the context of prostate cancer biology)
04
Biomarkers
PCGEM1 expression levels have been investigated as a biomarker for prostate cancer diagnosis and progression
Beyond the preview
Go deeper on Prostate-specific transcript 1 (PCGEM1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prostate-specific transcript 1 (PCGEM1).